Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

News

News
Trauma, Biological Factors Increase Women’s Vulnerability to Severe AUDs
07/13/2022
An increased risk of personal histories of trauma combined with a greater vulnerability to alcohol-related deficits in the brain appear to work together to lead to more severe alcohol use disorders in women compared with men.
An increased risk of personal histories of trauma combined with a greater vulnerability to alcohol-related deficits in the brain appear to work together to lead to more severe alcohol use disorders in women compared with men.
An increased risk of personal...
07/13/2022
Psych Congress Network

Advertisement

News
ADHD Medications May Treat Symptoms of Alzheimer Disease
07/13/2022
Noradrenergic medications, such as atomoxetine, methylphenidate, and guanfacine, may benefit people with Alzheimer disease and are worthy of further investigation in patients.
Noradrenergic medications, such as atomoxetine, methylphenidate, and guanfacine, may benefit people with Alzheimer disease and are worthy of further investigation in patients.
Noradrenergic medications, such...
07/13/2022
Psych Congress Network
News
Women with PTSD Show Accelerated Cognitive Decline in Midlife
07/12/2022
Post-traumatic stress disorder (PTSD) was associated with accelerated cognitive decline in middle-aged women, according to a large-scale prospective cohort study.
Post-traumatic stress disorder (PTSD) was associated with accelerated cognitive decline in middle-aged women, according to a large-scale prospective cohort study.
Post-traumatic stress disorder...
07/12/2022
Psych Congress Network
News
Fewer Fruit and Veggies, More Inattention in Children with ADHD
07/12/2022
A higher intake of fruits and vegetables was inversely associated with inattention in children with attention-deficit/hyperactivity disorder (ADHD), according to a study published in Nutritional Neuroscience.
A higher intake of fruits and vegetables was inversely associated with inattention in children with attention-deficit/hyperactivity disorder (ADHD), according to a study published in Nutritional Neuroscience.
A higher intake of fruits and...
07/12/2022
Psych Congress Network

Advertisement

News
Eptinezumab Reduces Migraine Days in Adults With Previous Treatment Failures
07/12/2022
Early trial results offer hope to those suffering from chronic, refractory migraine that failed other treatments, like sumatriptan and other medications.
Early trial results offer hope to those suffering from chronic, refractory migraine that failed other treatments, like sumatriptan and other medications.
Early trial results offer hope...
07/12/2022
Neurology
News
Just 1 in 5 Patients With Alcohol-Related Diagnosis Prescribed Medication to Treat AUD
07/07/2022
The findings indicate underprescribing of such medications, despite their demonstrated effectiveness in reducing heavy drinking and/or relapse.
The findings indicate underprescribing of such medications, despite their demonstrated effectiveness in reducing heavy drinking and/or relapse.
The findings indicate...
07/07/2022
Psych Congress Network
News
Learning Not Impacted by Stimulant Medication in Pediatric ADHD
07/06/2022
Although stimulant medication significantly affected seatwork productivity and classroom behavior in children with attention-deficit/hyperactivity disorder (ADHD), it had no detectable impact on learning the material taught, according to a...
Although stimulant medication significantly affected seatwork productivity and classroom behavior in children with attention-deficit/hyperactivity disorder (ADHD), it had no detectable impact on learning the material taught, according to a...
Although stimulant medication...
07/06/2022
Psych Congress Network

Advertisement

News
Cognitive Improvement Helps Drive Function Gains in Patients With Schizophrenia
07/05/2022
Cognitive gains partially mediate the relationship between cognitive enhancement therapy (CET) and improved functional capacity in people with schizophrenia, according to a new study.
Cognitive gains partially mediate the relationship between cognitive enhancement therapy (CET) and improved functional capacity in people with schizophrenia, according to a new study.
Cognitive gains partially...
07/05/2022
Psych Congress Network
News
Current Depression Associated With Increased Cardiovascular Risk
07/05/2022
Primary care patients with current depression had significantly higher cardiovascular risk compared with patients with controlled depression and patients without depression, according to study findings.
Primary care patients with current depression had significantly higher cardiovascular risk compared with patients with controlled depression and patients without depression, according to study findings.
Primary care patients with...
07/05/2022
Psych Congress Network
News
Pharmacotherapy for Alcohol Use Disorder Associated With Lower Odds of Liver Disease
06/29/2022
In people with alcohol use disorder, medical addiction pharmacotherapy is linked with reduced incidence and progression of alcohol-associated liver disease, according to study findings published online in JAMA Network Open.
In people with alcohol use disorder, medical addiction pharmacotherapy is linked with reduced incidence and progression of alcohol-associated liver disease, according to study findings published online in JAMA Network Open.
In people with alcohol use...
06/29/2022
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use